Drug Trial Radar · NCT03789006
Antithymocyte Globulin and Azathioprine Versus Basiliximab and Mycophenolate Mofetil in Living Donor Kidney Transplantation
Last checked: Nov 19, 2026Latest source record: Jan 3, 2019 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
300
Planned (sponsor's estimate)
Start
Mar 21, 2018
Primary completion
Mar 21, 2022
Study completion Mar 21, 2024
Sponsor
- Lead sponsor
- University of KhartoumAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- National Center for Kidney Diseases and Surgery
- First posted
- Dec 28, 2018
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Prevention
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Kidney transplantation is the best available treatment option for patients with end stage renal disease. However, kidney transplantation requires life-long use of immunosuppressive medication. Because of the high cost of these medications we need to carefully evaluate the cost-effectiveness of each drug regimen, especially in low-middle income countries. The objective of this clinical trial is to compare the efficiency and cost of two immunosuppressive protocols after living donor kidney transplantation: (1) antithymocyte globulin, tacrolimus, azathioprine and prednisolone versus (2) basiliximab, tacrolimus, mycophenolate mofetil and prednisolone.
Conditions
- Kidney Transplant Rejection
Interventions
Antithymocyte Immunoglobulin (Rabbit)Drug
Induction agent for living donor kidney transplantation
Interleukin 2 Receptor AntagonistDrug
Induction agent for living donor kidney transplantation
Primary outcomes
What the sponsor says the trial is designed to measure.
- Incidence of acute rejectionTime frame: 6 months post kidney transplant
- One year graft survivalTime frame: 1 year post kidney transplant
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Doctor Salma Center for Kidney Diseases
Khartoum, Sudan · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.